Vitamin D receptor gene polymorphism as possible risk factor in rheumatoid arthritis and rheumatoid related osteoporosis

被引:87
作者
Mosaad, Youssef M. [1 ]
Hammad, Enas M. [2 ]
Fawzy, Zakaria [1 ]
Aal, Ibrahim A. Abdal [3 ]
Youssef, Hazem M. [2 ,4 ]
ElSaid, Tamer O. [2 ]
Monir, Rehan [5 ]
EL-Deek, Basem S. [6 ,7 ]
机构
[1] Mansoura Fac Med, Dept Clin Pathol, Clin Immunol Unit, Mansoura, Egypt
[2] Mansoura Univ Hosp, Rheumatol & Rehabil Dept, Mansoura, Egypt
[3] Mansoura Fac Med, Dept Clin Pathol, Clin Chem Unit, Mansoura, Egypt
[4] Aberdeen Royal Infirm, Dept Rheumatol, Aberdeen, Scotland
[5] Mansoura Fac Med, Dept Med Biochem, Mansoura, Egypt
[6] Mansoura Fac Med, Community Med & Stat Dept, Mansoura, Egypt
[7] King Abdulaziz Univ, Fac Med, Res Unit, Jeddah 21413, Saudi Arabia
关键词
BONE-MINERAL DENSITY; VDR GENE; DISEASE-ACTIVITY; ASSOCIATION; POSTMENOPAUSAL; TURNOVER; ALLELES; GENOTYPES; SEVERITY; CANCER;
D O I
10.1016/j.humimm.2014.02.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Objective: To study the role of VDR polymorphisms as risk factor for RA and osteoporosis, and whether osteoporosis complicating RA is due to RA or VDR polymorphisms. Methods: VDR gene polymorphisms Apar, TaqI, BsmI and FokI were typed by RFLP for 128 RA patients, 30 postmenopausal osteoporotic females and 150 healthy controls. Results: Significant differences were found between patients and healthy controls in the frequency of BsmI and TaqI (Pc < 0.05) but no significant associations were found for Fold and Apar polymorphisms except for aa genotype (Pc < 0.001). Titers of RF were higher with aa and bb genotypes. Anti-CCP and CRP levels were higher with aa genotype and more bone loss was associated with Bb genotype. Ff genotype frequency was higher in RA patients with osteoporosis than those without osteoporosis. Conclusions: The Apar, BsrnI and TaqI polymorphisms may be a susceptibility risk factors for RA and the Ff genotype may be responsible for development of osteoporosis in RA Egyptian patients. However, the present study needs to be replicated in a large number of patients from allover the Egypt and also in multi-ethnic populations. (C) 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:452 / 461
页数:10
相关论文
共 61 条
[1]
Control of autoimmune diseases by the vitamin D endocrine system [J].
Adorini, Luciano ;
Penna, Giuseppe .
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (08) :404-412
[2]
Epidemiology of adult rheumatoid arthritis [J].
Alamanos, Y ;
Drosos, AA .
AUTOIMMUNITY REVIEWS, 2005, 4 (03) :130-136
[3]
Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]
[4]
Andjelkovic Z, 1999, CLIN EXP RHEUMATOL, V17, P453
[5]
[Anonymous], 1994, WHO TECHN REP SER, V843
[6]
Vitamin D Receptor Gene Polymorphisms in Rheumatoid Arthritis [J].
Ates, Omer ;
Dolek, Bilgen ;
Dalyan, Levent ;
Topal-Sarikaya, Aysegul .
TURKISH JOURNAL OF RHEUMATOLOGY, 2011, 26 (02) :145-149
[7]
Development and assessment of indicators of rheumatoid arthritis severity: Results of a Delphi panel [J].
Cabral, D ;
Katz, JN ;
Weinblatt, ME ;
Ting, G ;
Avorn, J ;
Solomon, DH .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (01) :61-66
[8]
1,25-dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis [J].
Cantorna, MT ;
Hayes, CE ;
DeLuca, HF .
JOURNAL OF NUTRITION, 1998, 128 (01) :68-72
[9]
Cortet B, 1997, REV RHUM, V64, P451
[10]
Vitamin D and autoimmune rheumatic diseases [J].
Cutolo, M. .
RHEUMATOLOGY, 2009, 48 (03) :210-212